Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

10x Genomics (TXG) Non-Current Assets (2018 - 2025)

Historic Non-Current Assets for 10x Genomics (TXG) over the last 8 years, with Q4 2025 value amounting to $356.9 million.

  • 10x Genomics' Non-Current Assets rose 678.09% to $356.9 million in Q4 2025 from the same period last year, while for Dec 2025 it was $1.4 billion, marking a year-over-year decrease of 87.13%. This contributed to the annual value of $356.9 million for FY2025, which is 678.09% up from last year.
  • Latest data reveals that 10x Genomics reported Non-Current Assets of $356.9 million as of Q4 2025, which was up 678.09% from $367.5 million recorded in Q3 2025.
  • In the past 5 years, 10x Genomics' Non-Current Assets ranged from a high of $412.1 million in Q1 2023 and a low of $208.3 million during Q1 2021
  • Over the past 5 years, 10x Genomics' median Non-Current Assets value was $347.2 million (recorded in 2024), while the average stood at $334.0 million.
  • As far as peak fluctuations go, 10x Genomics' Non-Current Assets soared by 7501.86% in 2021, and later plummeted by 1381.49% in 2024.
  • Over the past 5 years, 10x Genomics' Non-Current Assets (Quarter) stood at $271.2 million in 2021, then soared by 45.24% to $393.9 million in 2022, then dropped by 6.3% to $369.1 million in 2023, then dropped by 9.45% to $334.2 million in 2024, then increased by 6.78% to $356.9 million in 2025.
  • Its last three reported values are $356.9 million in Q4 2025, $367.5 million for Q3 2025, and $324.3 million during Q2 2025.